Halobetasol propionate and Headache - a phase IV clinical study of FDA data

Summary:

Headache is reported as a side effect among people who take Halobetasol propionate (halobetasol propionate), especially for people who are female, 60+ old, also take Triamcinolone, and have Psoriasis.

The phase IV clinical study analyzes which people have Headache when taking Halobetasol propionate. It is created by eHealthMe based on reports of 853 people who have side effects when taking Halobetasol propionate from the FDA, and is updated regularly.

What is Halobetasol propionate?

Halobetasol propionate has active ingredients of halobetasol propionate. eHealthMe is studying from 863 Halobetasol propionate users. Check the latest studies of Halobetasol propionate.

What is Headache?

Headache (pain in head) is found to be associated with 3,754 drugs and 5,775 conditions by eHealthMe. Check the latest studies of Headache.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

853 people reported to have side effects when taking Halobetasol propionate.
Among them, 32 people (3.75%) have Headache.

Could Halobetasol propionate cause Headache?

Among these 32 people:

What is the gender of people who have Headache when taking Halobetasol propionate? *

female: 61.29 %
male: 38.71 %

What is the age of people who have Headache when taking Halobetasol propionate? *

What are other drugs people take besides Halobetasol propionate? *

What are other side effects people have besides Headache? *

Fatigue (feeling of tiredness): 16 people, 50.00%
Itching: 12 people, 37.50%
Dyspnea (difficult or laboured breathing): 11 people, 34.38%
Influenza Like Illness: 9 people, 28.12%
Psoriasis (immune-mediated disease that affects the skin): 9 people, 28.12%
Sinusitis (inflammation of sinus): 9 people, 28.12%
Drowsiness: 9 people, 28.12%
Nasopharyngitis (inflammation of the nasopharynx): 8 people, 25.00%
Nausea (feeling of having an urge to vomit): 8 people, 25.00%
Chills (felling of cold): 8 people, 25.00%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 13 people, 40.62%
Immunodeficiency Common Variable: 6 people, 18.75%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 5 people, 15.62%
Constipation: 2 people, 6.25%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 6.25%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 6.25%
Primary Immunodeficiency Syndrome: 2 people, 6.25%
Muscle Spasms (muscle contraction): 2 people, 6.25%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 1 person, 3.12%
Folliculitis (infection of hair root): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Halobetasol propionate and have Headache?

- Check whether Headache is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Halobetasol propionate:

Halobetasol propionate (863 reports)

Headache treatments and more:

Headache (756,642 reports)

Browse all side effects of Halobetasol propionate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Headache:

Headache (3,754 drugs)

Browse all the conditions that are associated with Headache:

Headache (5,775 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on halobetasol propionate (the active ingredients of Halobetasol propionate) and Halobetasol propionate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.